Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Yusa

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Nature Communications|January 10, 2019
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forksGabriel Balmus, Domenic Pilger, Julia Coates, et al.
Cancer Cell|July 13, 2013
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic interventionRoland Rad, Juan Cadiñanos, Lena Rad, et al.
Nature Communications|December 22, 2019
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M Dempster, Clare Pacini, Sasha Pantel, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Nature Genetics|February 2, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Cell Reports|October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Nature Communications|December 21, 2018
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4Konstantinos Tzelepis, Etienne De Braekeleer, Demetrios Aspris, et al.
Blood Advances|October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Nature Communications|January 10, 2019
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forksGabriel Balmus, Domenic Pilger, Julia Coates, et al.
Cancer Cell|July 13, 2013
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic interventionRoland Rad, Juan Cadiñanos, Lena Rad, et al.
Nature Communications|December 22, 2019
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M Dempster, Clare Pacini, Sasha Pantel, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Nature Genetics|February 2, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Cell Reports|October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Nature Communications|December 21, 2018
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4Konstantinos Tzelepis, Etienne De Braekeleer, Demetrios Aspris, et al.
Blood Advances|October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Pageof 9